To include your compound in the COVID-19 Resource Center, submit it here.

Celularity unveils size of series A

Celularity Inc. (Warren, N.J.) revealed on Feb. 15 that it has raised more than $250 million in series A funding and assets from Celgene

Read the full 247 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE